Cryosurgery, the technique behind CryoPen, is one of the most established treatment modalities in outpatient dermatology. Two independent, peer-reviewed sources summarise the evidence clearly:
In Vivo / PMC (2025)
A comprehensive review of cutaneous cryosurgery across benign, premalignant, and malignant lesions found it offers distinct advantages over many established treatments due to its safety, efficiency, feasibility, and cost-effectiveness, with strong adaptability across a broad range of patient populations.
Read the full study here →
American Academy of Family Physicians (2020)
A structured clinical review, drawing on PubMed, the Cochrane database, and other major evidence sources, described cutaneous cryosurgery as valued specifically for its safety, effectiveness, low cost, ease of use, lack of need for injectable anaesthetic, and good cosmetic results.
Read the full study here →
The conclusion across both sources is consistent: cryosurgery is a genuinely well-evidenced, low-risk treatment, not a newer or less-tested alternative, but one of the most established techniques in dermatology.